J. Reed is a distinguished leader in the pharmaceutical industry, currently serving as the Executive Vice President (EVP) of Innovative Medicine, Research and Development (R&D) at Johnson & Johnson. With a robust background in medicine and a passion for scientific innovation, Reed has been instrumental in steering Johnson & Johnson's efforts to develop groundbreaking treatments and therapies. Prior to joining Johnson & Johnson, Reed held various leadership roles at other major pharmaceutical companies, where he honed his skills in drug development and clinical research. At Johnson & Johnson, Reed's role as EVP of Innovative Medicine, R&D is pivotal in driving the company's mission to advance healthcare through cutting-edge research. He oversees a diverse portfolio of projects spanning multiple therapeutic areas, including oncology, immunology, and neuroscience. Under his leadership, Johnson & Johnson has made significant strides in bringing new drugs to market, notably with the development of novel cancer therapies and treatments for autoimmune diseases. Reed's strategic vision and commitment to scientific excellence have been key factors in the company's continued success and growth in the highly competitive pharmaceutical landscape. In addition to his corporate responsibilities, J. Reed is an active member of the scientific community, frequently contributing to peer-reviewed journals and participating in international conferences. His dedication to advancing medical knowledge and improving patient outcomes has earned him numerous accolades and recognition within the industry. Reed's leadership at Johnson & Johnson not only underscores his professional achievements but also reflects his unwavering commitment to making a meaningful impact on global health.